Immunopharmacology & Hematologic Pharmacology | Methods for Diagnostic & Therapeutic Studies | Multiple Sclerosis & Related Disorders
Cause of death in patients with multiple sclerosis: The 21-year long-term follow-up study
George C Ebers*, Douglas S Goodin, Anthony T Reder, Gary Cutter, Marcelo Kremenchutzky, Joel Oger, Dawn Langdon, Mark Rametta, Karola Beckmann, Volker Knappertz
*Corresponding author: George C Ebers
University Department of Clinical Neurology, John Radcliffe Hospital, Oxford, UK
F1000Posters 2011, 2: 866 (poster) [ENGLISH]
Poster [373.45 KB]
Presented at
21st Meeting of the European Neurological Society 2011,
28 - 31 May 2011, P429
This study examined the underlying causes-of-death in 81 deceased patients identified 21 years after their participation in the randomised controlled trial of interferon beta-1b (IFNB-1b; Betaferon®) in multiple sclerosis.
In this cohort of patients, a significant survival advantage in favor of early IFNB-1b treatment versus placebo was found. A total of 82% of deaths with cause-of-death information were adjudicated to be MS-related.
No relevant conflicts of interest declared.
Please note that most posters on this site present work that is preliminary in nature and has not been peer reviewed.
This poster is open access subject to the CC BY-NC Creative Commons 3.0 License
